APA (7th ed.) Citation

KJ, K., R, H., M, S., B, P., T, S., A, T., . . . M, F. (2013). A novel, disruptive vaccination technology: Self-adjuvanted RNActive(®) vaccines. Human vaccines & immunotherapeutics, 9(10), 2263. https://doi.org/10.4161/hv.25181

Chicago Style (17th ed.) Citation

KJ, Kallen, et al. "A Novel, Disruptive Vaccination Technology: Self-adjuvanted RNActive(®) Vaccines." Human Vaccines & Immunotherapeutics 9, no. 10 (2013): 2263. https://doi.org/10.4161/hv.25181.

MLA (9th ed.) Citation

KJ, Kallen, et al. "A Novel, Disruptive Vaccination Technology: Self-adjuvanted RNActive(®) Vaccines." Human Vaccines & Immunotherapeutics, vol. 9, no. 10, 2013, p. 2263, https://doi.org/10.4161/hv.25181.